The microtubule associated protein syntabulin is required for glucose-stimulated and cAMP-potentiated insulin secretion  by Ying, Ying et al.
FEBS Letters 586 (2012) 3674–3680journal homepage: www.FEBSLetters .orgThe microtubule associated protein syntabulin is required for glucose-stimulated
and cAMP-potentiated insulin secretion
Ying Ying a,b, Lingyun Li b, Wen Cao b, Dan Yan a,b, Qing Zeng a,b, Xiangchen Kong a,b, Lina Lu a,b,
Meng Yan a,c, Xiaohui Xu a, Junle Qu c, Qingning Su b,⇑, Xiaosong Ma a,b,⇑
aDept. of Physiology, School of Medicine, Shenzhen University, Shenzhen 518060, PR China
bDiabetes Center of Shenzhen University, Shenzhen 518060, PR China
cCollege of Optoelectronic Engineering, Shenzhen University, Shenzhen, PR Chinaa r t i c l e i n f o
Article history:
Received 7 May 2012
Revised 23 August 2012
Accepted 25 August 2012
Available online 6 September 2012







INS-1E cell0014-5793/$36.00  2012 Federation of European Bio
http://dx.doi.org/10.1016/j.febslet.2012.08.025
⇑ Corresponding authors. Address: School of Me
Shenzhen 518060, PR China. Fax: +86 0755 26635
86671906 (X. Ma).
E-mail addresses: sqn@szu.edu.cn (Q. Su), xsma@sa b s t r a c t
Syntabulin is a microtubule-associated protein that mediates anterograde transport of vesicles to
neuronal processes. Here, we found that syntabulin was expressed in mouse pancreas and
insulin-secreting b-cells, and that it partially co-localized with microtubule and insulin-containing
granules. The association of syntabulin with these organelles increased upon glucose stimulation.
Knock-down of syntabulin by shRNA reduced both basal and glucose-stimulated insulin secretion,
and diminished cAMP-Epac2 and cAMP-PKA potentiated insulin secretion. Additionally, syntabulin
was preferentially phosphorylated by the Epac2 agonist 8-pCPT-20-O-Me-cAMP, suggesting that syn-
tabulin could be a novel effector of Epac2 and play a critical role in cAMP-enhanced insulin
secretion.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glucose-stimulated insulin secretion involves both fusion at the
plasma membrane of insulin-containing granules of a readily reli-
able pool (RRP) and the mobilization and trafﬁcking of insulin-con-
taining granules to the cell surface from intracellular reserve pools
[1,2]. These events are triggered by increased glucose ﬂux into
b-cells, resulting in increased glycolysis and an elevation in the intra-
cellular ATP/ADP ratio and leading to the closure of KATP-channels
and depolarizing cell membrane, opening voltage-gated calcium
channels, and increased cytosolic calcium concentration [3–5]. It
is well established that this increase in intracellular calcium is a
necessary trigger for insulin secretion and is thought to regulate
both the initial exocytosis of primed granules and subsequent traf-
ﬁcking/mobilization of stored insulin granules [6]. Previous studies
have disclosed that recruitment of insulin-containing granules to
the plasma membrane driven by kinesins plays a critical role in
sustained glucose-stimulated insulin secretion and involves gran-
ule transport along microtubules, thus important for the secondchemical Societies. Published by E
dicine, Shenzhen University,
990 (Q. Su), fax: +86 0755
zu.edu.cn (X. Ma).phase of insulin secretion [7,8]. It is now known that microtu-
bule-based granule transport involves both rapid and slow compo-
nent of exocytosis [9,10], and therefore is required for both phases
of glucose-induced insulin secretion [11]. Kinesins are microtu-
bule-dependent ATPase that use ATP hydrolysis to move cargoes
along microtubules [12]. It has been found that kinesin is required
for axonal transport in neuronal cells [13] and recruits granules to
the release sites of Ca2+-regulated exocytosis in sea urchin embryos
[14]. Three conventional kinesin genes (Kif5a, Kif5b and Kif5c) have
been identiﬁed [8]. Among which Kif5b is expressed in primary
mouse pancreatic b-cells [15] and involved in trafﬁcking and exo-
cytosis of insulin-containing granules [8].
Syntabulin is a kinesin-1 family membrane 5B (Kif5b) adaptor
protein and a microtubule-associated protein that mediates anter-
ograde transport of syntaxin-1 to neuronal processes [16]. It has
been found that syntabulin functions as a linker molecule by
attaching the cargo vesicles to conventional kinesin I and mediat-
ing the transport of cargo vesicles to the neuronal processes [16].
In live hippocampal neurons syntabulin was found to co-localize
and co-migrate with GFP-Bassoon-labeled vesicles alone axonal
processes [17]. Knock-down of syntabulin results in the impaired
trafﬁcking of synaptic vesicles to nerve terminals and thus dimin-
ishes synaptic transmission [17]. Moreover, expression of syntabu-
lin dominant-negative mutants or suppression of syntabulinlsevier B.V. All rights reserved.
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at release sites [17]. All these studies indicate that syntabulin func-
tions as a linker molecule of vesicles and microtubules, and is
essential for vesicle trafﬁcking and exocytosis. In this study we
for the ﬁrst time show that syntabulin is also present in pancreas
and insulin-secreting b-cells. As its role for maintenance of neuro-
transmission, syntabulin is essential for glucose-stimulated insulin
secretion and cAMP-potentiated insulin secretion.2. Materials and methods
2.1. Animal experiments
Female C57BL/6 mice (4-6w) were purchased from the Experi-
mental Animal Centre of Guangdong Academy of Medical Science
(Guangzhou, China). The mice were killed by cervical dislocation.
Tissues from brain and pancreas were isolated for Western blot
analysis. All animal procedures were carried out according to the
Principles of Laboratory Animal Care and approved by the
Shenzhen University Animal Care Committee.
2.2. Cell lines and cell culture
MIN6 cells were kindly provided by Professor Xiaoying Li from
Shanghai Institute of Endocrine and Metabolic Diseases. MIN6 cells
(passages 31–42) were grown in Dulbecco’s modiﬁed eagle med-
ium (DMEM) containing 25 mM glucose supplemented with 15%
(w/v) heat inactivated fetal bovine serum, 10 mM HEPES buffer,
50 lM beta-mercaptoethanol (Sigma Aldrich), 100 lM penicillin
G and 100 mg/ml streptomycin [18]. INS-1E cells were kindly pro-
vided by Professor Yong Liu from Shanghai Institue for Nuitritional
Sciences of Chinese Academy of Sciences. INS-1E cells (passages
48–60) were grown in RPMI1640 medium supplemented with
10% (w/v) fetal bovine serum, 10 mM HEPES buffer, 1 mM sodium
pyruvate, 50 lM beta-mercaptoethanol, 100 lM penicillin G and
100 mg/ml streptomycin. All cells were constantly kept at 37 C
in a humidiﬁed atmosphere of 95% air and 5% CO2.
2.3. RT-PCR
Total RNA from INS-1E cells was isolated using TRIzol Reagent
(Invitrogen) according to the manufacturer’s instructions. One
microgram of total RNA was reverse transcribed to single-stranded
cDNA using random hexamer primers and Superscript II (Invitro-
gen). The cDNA from the reverse transcription reactions was used
for ampliﬁcation using the following protocol: 2 min at 95 C, 32
cycles of 30 s at 95 C, 30 s at 55 C and 30 s at 72 C. Primers used
were human-syntabulin-F: 50-ATG GTG ACT GCC ACC ACC ACA; hu-
man-syntabulin-R: 50-TTA GGT TTT CAT GTG GAA AGC; human-
insulin-F: 50-ATG GCC CTG TGG ATG CGC CTC; human-insulin-R:
50-CTA GTT GCA GTA GTT CTC CAG. PCR products were analyzed
on a 2% agarose gel and conﬁrmed by sequencing.
2.4. Western blot
A 10 mm tissue segment or cell pellets were incubated in lysis
buffer (RIPA, BioTeke) supplemented with 1 mM protease inhibitor
cocktail (CALBIOCHEM) for 30 min on ice, followed by centrifuga-
tion at 14,000 rpm for 15 min at 4 C. Equivalent protein amounts
were resolved using SDS–PAGE gels and transferred onto a polyvi-
nylidene diﬂuoride (PVDF) membrane by electrophoresis. The
membranes were immunoblotted with the following primary anti-
bodies: polyclonal rat-anti syntabulin (Santa Cruze Biotechnology,
1:1500); polyclonal rat anti-phosphorylated syntabulin (1:500)
and polyclonal rat anti-b-actin (Santa Cruz Biotechnology,1:1000,) overnight at 4 C, followed by incubation with a horse-
radish-peroxidase-conjugated goat anti-rabbit secondary antibody
(Cell Signaling, 1:1000) at room temperature for 1 h. Immunoreac-
tive bands were revealed by enhanced chemiluminescence (Super-
Signal West Pico Chemiluminescent Substrate kits, Thermo
Scientiﬁc) and visualized by the KODAK Image Station 4000MM
PRO imaging system and software according to the manufacture’s
instruction. Band intensities were quantiﬁed by scanning densi-
tometry (Gel-Doc2000, Bio-Rad), analyzed with Quantity One™
(Bio-Rad) and normalized against the level of b-actin.
2.5. Indirect immunoﬂuorescence and confocal microscopy
INS-1E cells cultured on glass coverslips were ﬁxed with 100%
ice-cold methanol for 10 min at 20 C. After blocking unspeciﬁc
binding by incubating for 30 min with 1% BSA, cells were incubated
overnight at 4 C in the presence of a rabbit anti-syntabulin anti-
body (1:100) and a mouse anti-a-tubulin antibody (Abcam,
1:100); a rabbit anti-insulin antibody (Cell Signaling, 1:100) and
a mouse anti-a-tubulin antibody (1:100); or a rabbit anti-syntabu-
lin antibody (1:100) and a mouse anti-insulin antibody (1:100),
respectively. Cells were then incubated at 37 C for 1 h with
Alexa-Fluor488-labeled goat anti-mouse (Invitrogen, 1:100) and
Alexa-Fluor546-labeled goat anti-rabbit (Invitrogen, 1:100) sec-
ondary antibodies. Images were obtained with an OLYMPUS
FV1000 confocal laser-scanning microscope.
2.6. Immunoprecipitation
Two microliter of normal rabbit IgG and 2 ll of rabbit antibody
speciﬁc to syntabulin (Santa Cruz) were incubated with Protein A/
G beads with 300 ll TBST (0.1% Triton X-100) respectively over-
night at 4 C with gentle rotation. After three washes with TBST,
cell lysates of different treated cells were added to each tube and
incubated for 3 h at 4 C. After extensive washing, proteins remain-
ing bound to the beads were then analyzed by Western blot with
monoclonal antibody speciﬁc to microtubule (Abcam, 1:2000).
2.7. Knock-down of syntabulin by RNA interference
Adenoviral short hairpin RNA for rat and mouse syntabulin
pAd-syntabulin-shRNA (Syntabulin-shRNA) were constructed by
inserting double-stranded oligo DNA with EcoRI and BamHI restric-
tion enzyme sites (AATTCagacttgagctccatgatttcagaagctgtctgaaat-
catggagctcaagtctaataaaG and
GATCCtttattagacttgagctccatgatttcagacagcttctgaaatcatggagct-
caagtctG) into the adenovirus vector with reporter gene GFP cut by
the same enzymes. The plasmid constructs were conﬁrmed by
sequencing. 2  105 INS-1E cells were seeded in 12-well plates
one day before transfection. Cells (80% conﬂuence) were then
transfected with 1.6 lg Syntabulin-shRNA or vector control using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
protocol. Seventy-two hours after transfection, the expression of
syntabulin was analyzed by Western blot with b-actin as an inter-
nal control. The knock-down efﬁciency was quantiﬁed and normal-
ized against the level of b-actin.
2.8. Measurements of insulin secretion
2  105 INS-1E cells were seeded in 12-well plates one day be-
fore transfection and then transfected with 1.6 lg Syntabulin-
shRNA or vector control using Lipofecta mine 2000 (Invitrogen).
Seventy-two hours after transfection, INS-1E cells were washed
twice with KRB (containing in mM: 129 NaCl, 4.8 KCl, 1 CaCl2,
1.2 MgSO4, 1.2 KH2PO4, 5 NaHCO3, 2.8 glucose, and 10 HEPES, sup-
plemented with 0.1% BSA, pH 7.4) and preincubated in 1 ml KRB
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by 1 ml KRB containing 2.8 mM glucose or 16.8 mM glucose
alone, or in the presence of 10 lM forskolin (FSK)(Sigma),
100 lM 6-BNZ-cAMP-AM (6-BNZ) (Biolog Life Science), 1 lM
8-pCPT-20-O-Me-cAMP (ESCA-AM) (Biolog Life Science) for
30 min, respectively. The supernatants were collected for measure-
ments of secreted insulin and the attached cells were harvested for
determination of total cellular protein content and protein expres-
sion. Insulin secretion was assayed by an Insulin (Rat) Ultrasensi-
tive ELISA kit (ALPCO Diagnostics). Insulin levels (ng/ml) were
normalized against total cellular protein content in mg and
expressed as percentage change as compared with vector control.
2.9. Statistical analyses
All data were expressed as mean ± S.E.M. To test for statistical
signiﬁcance an unpaired Student’s t-test was applied. Data were
considered signiﬁcant when P < 0.05.
3. Results
3.1. Syntabulin is expressed in mouse pancreas and insulin-secreting
b-cells, and co-localized with microtubule and insulin-containing
granules
Syntabulin is a microtubule associated protein and widely ex-
pressed in different tissues including brain, liver, heart, etc. [16].
Northern blotting results suggested that syntabulin was expressed
in human pancreas (Su et al., unpublished data). We therefore
tested whether syntabulin was also expressed in mouse pancreas
using Western blot analysis. Results showed that syntabulin was
not only expressed in mouse brain as reported previously [16],
but also expressed in mouse pancreas (Fig. 1A). In addition syntab-
ulin was readily detected in insulin-secreting INS-1E cells and
MIN6 cells as determined by RT-PCR (Fig. 1B) and Western blot
(Fig. 1C), respectively.
In hippocampal neurons syntabulin has been found to attach
secretory vesicles to microtubules [16], we next determined the
subcellular distribution of syntabulin in INS-1E cells. Confocal ﬂuo-
rescence images clearly showed that both syntabulin and insulin-
containing granules were abundantly expressed in the cytoplasm
of INS-1E cells and resided in multiple granulated foci. At
un-stimulated conditions a few co-localizations of syntabulin
(Fig. 2A; Suppl. Fig. 2) or insulin (Fig. 2B; Suppl. Fig. 2) with micro-
tubule were observed. Accordingly some of syntabulin was co-
localized with insulin-containing granules (Fig. 2C; Suppl. Fig. 2)
in this case. By contrast, when INS-1E cells were stimulated with
16.8 mM glucose, co-localizations of syntabulin (Fig. 2D;
Suppl. Fig. 3) or insulin (Fig. 2E; Suppl. Fig. 3) with microtubule
were increased. The association of syntabulin with microtubule
was further conﬁrmed by immunoprecipitation assay (Fig.3). Inter-
estingly upon 1 min (Suppl. Fig. 1C) or 10 min (Fig. 2F) of 16.8 mM
glucose stimulation, syntabulin was readily detected to be co-
localize with insulin-containing granules in the cytosol (Fig. 2F,Fig. 1. Syntabulin expression in mouse pancreas and insulin-secreting b-cell lines. (A) Ide
blot. b-Actin was used as an internal control. (B) Syntabulin mRNA expression in INS-1E
protein expression in MIN6 cells was conﬁrmed by Western blot with b-actin as an inteSuppl. Fig. 1C), although many insulin-containing granules evi-
dently resided at the plasma membrane. These data indicate that
syntabulin may involve in the glucose-regulated microtubule-
based translocation of insulin-containing granules.
3.2. Knock-down of syntabulin inhibits glucose-stimulated insulin
secretion
Next we explored the importance of syntabulin for insulin
secretion in b-cells. First, we adopted a short hairpin RNA (shRNA)
approach to knockdown syntabulin in INS-1E cells. Transient trans-
fection of INS-1E cells with adenoviral vectors coding for shRNA
constructs against syntabulin resulted in decreased protein expres-
sion of syntabulin as determined by Western blot (Fig. 4A). Quan-
titative analysis of knock-down of syntabulin using shRNA
revealed a 45% decrease in syntabulin protein level, as compared
to vector control (Fig. 4B). The suppression efﬁciency using shRNA
in our study is comparable to the previous reports in neurons
[16,19]. Next, we assessed the effect of syntabulin downregulation
on insulin secretion in response to a glucose challenge in INS-1E
cells. In the syntabulin-downregulated cells insulin secretion in re-
sponse to 2.8 mM or 16.8 mM glucose was reduced by 11% or 37%,
respectively, in comparison to vector-transfected cells (Fig. 4C).
These data suggest that syntabulin is required for both basal and
glucose-stimulated insulin secretion.
3.3. Syntabulin is involved in cAMP-Epac2-potentiation of glucose-
stimulated insulin secretion
Epac2 is the key isoform of Epac (exchange protein directly
activated by cAMP) responsible for cAMP-regulated insulin secre-
tion in pancreatic b-cells [20,21]. It has been found that Epac di-
rectly interacts with microtubules and mediates cAMP-regulated
microtubule formation [22]. We therefore explored whether
syntabulin would be an effector of cAMP-Epac2 in INS-1E cells.
The level of syntabulin protein expression upon secretagogue
stimulation was determined by Western blot. Application of
10 lM forskolin (a general stimulator of adenylyl cyclase) or
1 lM 8-pCPT-20-O-Me-cAMP (a speciﬁc Epac2 agonist) produced
a 1.72- or 1.70-fold increase (P < 0.05) in phosphorylated syntabu-
lin level, respectively, as comparison to control (Fig. 5A and B). By
contrast, addition of 100 lM 6-BNZ-cAMP (a selective PKA agonist)
exerted little effects (1.26-fold increase, P > 0.05), on phosphory-
lated syntabulin level (Fig. 5A and B). Forskolin, 8-pCPT-20-O-Me-
cAMP or 6-BNZ-cAMP did not alter the total syntabulin protein
level (Fig. 5A and B). These results suggest that syntabulin may
involve in cAMP-Epac2 signaling pathway.
We next determined the role of syntabulin in cAMP-Epac2-en-
hanced glucose-stimulated insulin secretion in INS-1E cells. As
shown in Fig. 5C, speciﬁc knockdown of syntabulin diminished
the potency of forskolin, 6-BNZ or 8-CPT-20-O-Me-cAMP on
glucose-stimulated insulin secretion by 51% or 48% respectively,
as compared with vector-transfected cells (P < 0.01). Although
to a less extent compared to the cases of forskolin andntiﬁcation of syntabulin protein expression in mouse brain and pancreas byWestern
cells was determined by RT-PCR with insulin as an internal control. (C) Syntabulin
rnal control. Fibroblast was used as a negative control for syntabulin expression.
Fig. 2. Co-localization of syntabulin, microtubule and insulin-containing granules in INS-1E cells by indirect immunoﬂuorescence double staining. Distribution of
microtubule (green, left) and syntabulin (red, middle) and co-localization of the two (yellow, right) at basal condition (no glucose) (A) and stimulation with 16.8 mM glucose
for 10 min (D); microtubule (green, left) and insulin (red, middle) and co-localization of the two (yellow, right) at basal condition (B) and stimulation with 16.8 mM glucose
for 10 min (E); insulin (green, left) and syntabulin (red, middle) and co-localization of the two (yellow, right) at basal condition (C) and stimulation with 16.8 mM glucose for
10 min (F) in INS-1E cells. Scale bars represent 5 lm.
Fig. 3. Interaction of syntabulin with microtubule in INS-1E cells determined by
immunoprecipitation analysis. INS-1E cells were treated without or with 16.8 mM
glucose for 10 min, followed by immunoprecipitation with syntabulin antibody and
immunoblotting with antibody against microtubule. The faint bands shown in the
IgG lanes with almost the same size as microtubule are the IgG heavy chain.
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the potency of 6-BNZ on insulin secretion by 44% (P < 0.01). Thus
syntabulin is required for cAMP-linked-enhancement of glucose-
stimulated insulin secretion.
4. Discussion
Syntabulin is a Kif5b adaptor protein found in a variety of tis-
sues [16] and has been demonstrated to play a critical role in
anterograde transport of presynaptic cargoes including secretory
vesicles in neurons [16,23]. In this study we show that syntabulin
is also expressed in mouse pancreas (Fig. 1A) as well as in clonalb-cell lines (Fig. 1B and C). Moreover, syntabulin was largely pres-
ent in the cytoplasm of INS-1E cells and resided in multiple gran-
ulated foci (Fig. 2A, C, D and F). Different from its distribution
found in neurons and COS-7 cells where syntabulin was found to
distribute along microtubules and associate with vesicles or vesic-
ular-tubular structures [16], a few of co-localizations of syntabulin
with microtubule (Fig. 2A; Suppl. Fig. 2) or insulin-containing gran-
ules (Fig. 2C; Suppl. Fig. 2) were observed at no glucose conditions.
By contrast, the association of syntabulin with microtubules
(Fig. 2D; Suppl. Fig. 3) and insulin-containing granules was in-
creased in punctate structures within the cytoplasm of INS-1E cells
(Fig. 2F; Suppl. Fig. 3) upon glucose stimulation. Association of syn-
tabulin and microtubule was also supported by the data of immu-
noprecipitation assay (Fig. 3). Quantitative analysis revealed that
co-localization of syntabulin and microtubule was increased by
7% at high glucose (Suppl. Table 1), whereas an increase might
not be large enough to be detected by immunoprecipitation analy-
sis (Fig. 3). Nonetheless, these results suggest that the association
of syntabulin with microtubule and insulin-containing granules
is regulated by glucose.
It is well known that recruitment of insulin-containing granules
to the cell surface is essential for the both rapid and sustained insu-
lin secretion in response to glucose [8,24], a process that is medi-
ated by microtubule. Disruption of the microtubule network
impairs both the rapid and sustained component of exocytosis of
insulin-containing granules (monitored as depolarization-evoked
capacitance increases) by 50% [25]. To explore the functional
importance of granule-associated syntabulin, we suppressed syn-
tabulin expression in INS-1E cells with syntabulin-targeted shRNA.
This molecular approach results in a 45% decrease in syntabulin
protein level (Fig. 4A and B) and concomitant signiﬁcantly dimin-
ished glucose-stimulated insulin secretion (by 40%) as well as ba-
sal insulin secretion (by 10%). These effects on insulin secretion
Fig. 4. Effects of knock-down of syntabulin using shRNA on insulin secretion in INS-1E cells. (A) INS-1E cells were transiently transfected with pAd-syntabulin-shRNA
(Syntabulin-shRNA) or empty vector (vector). Expression of syntabulin was determined by Western blot using an antibody against syntabulin. b-actin was used as an internal
control. (B) Intensities of syntabulin protein expression were quantiﬁed, normalized against the level of b-actin and expressed as fold of protein abundance in INS-1E cells
transfected with vector control. Data are means ± S.E.M of six independent experiments in duplicate. **P < 0.01 vs. vector control. (C) Cells transfected with syntabulin-shRNA
or empty vector were ﬁrst preincubated for 1 h in KRB and then stimulated with 2.8 mM glucose or 16.8 mM glucose for 1 h. Insulin secretion was measured by ELISA. Insulin
levels (ng/ml) were normalized against total cellular protein content in mg and expressed as percentage change as compared with vector control. Data are means ± S.E.M of
six independent experiments in duplicate. *P < 0.05 and **P < 0.01 vs. vector control.
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containing granules was more evident during glucose stimulation
(Fig. 2F and Suppl. Fig. 1C), whereas rare at no glucose
(Fig. 2C). Consistently it has been reported that the numbers of
microtubule-based rapid granule movements were increased at
high glucose [7]. Therefore syntabulin is essential for the mainte-
nance of insulin secretion, particularly of glucose-stimulated insu-
lin secretion.
It has been proposed that the effects of glucose on microtubule-
based granule movements are mediated by the motor protein
kinesin. Transfection of INS-1 and MIN-6 cells with a dominant
negative kinesin heavy chain mutant abolished rapid granule
movements and sustained insulin secretion [8]. Kif5b as a mem-
brane of kinesin superfamily proteins expressed in primary mouse
pancreatic b-cells, and suppression of Kif5b with antisense oligo-
nucleotides blunted glucose-stimulated insulin secretion [15],
due to the severely slowed vesicle mobilization and decreased rate
of RRP replenishment [23]. We now extend these observations and
demonstrate that the maintenance of the secretory capacity of
pancreatic b-cells also requires the Kif5b adaptor protein syntabu-
lin. This notion is further supported by the observation that the
adaptor syntabulin conjoins kinesin and syntaxin-1 in forming
the complex of kinesin-syntabulin-syntaxin-1 that plays an essen-
tial role in synaptic vesicle anterograde transport [17].
The ability of cAMP-increasing agents to stimulate insulin secre-
tion is well established. cAMP action in insulin secretion is known
to be mediated through PKA and Epac2 [21,26]. Epac2 is a newly
recognized family of cAMP-binding proteins and mediates
cAMP-regulated exocytosis of insulin-containing granules [21,26].
Here we demonstrate that stimulation of Epac2 by forskolin or
8-pCPT-20-O-Me-cAMP signiﬁcantly increases phosphorylated syn-
tabulin level; whereas activation of PKA has little effects (Fig. 5Aand B). The precise molecular mechanisms underlying phosphory-
lation of syntabulin by Epac2 are not clear. It is known that subcel-
lular localization of Epacs is important for activation of downstream
signaling. For example targeting of Epac to perinuclear region is re-
quired for cAMP-mediated protein kinase B activation in HEK cells
[27]. It requires further studies to conﬁrm that stimulation of Epac2
involves in activation of PKB, and subsequently results in the
phosphorylation of syntabulin in pancreatic b-cells.
We also show that syntabulin is required for cAMP-Epac2 and
cAMP-PKA enhanced glucose stimulated insulin secretion
(Fig. 5C). Involvement of syntabulin in cAMP-Epac2 stimulated
insulin secretion would be understandable in terms of the observa-
tions that microtubule-associated protein (MAP) 1A is a protein-
binding partner for Epac1 and Epac2 via interaction of its light
chain with the catalytic domain of Epac [28]. Thus syntabulin could
be a novel effector of Epac2 and involve in cAMP-Epac2-regulated
insulin secretion in pancreatic b-cells. On the contrary, it is
perhaps unexpected to ﬁnd that syntabulin also involves in
cAMP-PKA-enhanced insulin secretion (Fig. 5C), given that the
PKA agonist 6-BNZ has little effects on phosphorylation of
syntabulin (Fig. 5A and B). These observations are not necessarily
contradictory because it has been found that PKA regulates micro-
tubule-based granule transport via phosphorylation of kinesin
[29], a component of the complex of kinesin-syntabulin-
syntaxin-1 [17]. Thus knock-down of syntabulin or disruption of
the complex would ultimately impair PKA-regulated granule trans-
port and secretion.
In summary, we demonstrate in this study that syntabulin as a
newmicrotubule associated protein involves in glucose-stimulated
insulin secretion. Importantly syntabulinmayact as a linkermolecule
connecting cAMP signaling and microtubule-based granule trans-
port, and play a critical role in cAMP-potentiated insulin secretion.
Fig. 5. Syntabulin is involved in cAMP-Epac2-potentiated glucose-stimulated insulin secretion in INS-1E cells. (A) INS-1E cells were stimulated by 16.8 mM glucose alone
(control), addition of 10 lM foskolin (FSK), 100 lM 6-BNZ-cAMP-AM (6-BNZ), or 1 lM 8-pCPT-20-O-Me-cAMP (ESCA-AM) for 15 min, respectively. Expression of total
syntabulin and phosphorylated-syntabulin (P-Syntabulin) under various stimulations was determined by Western blot using antibodies against total syntabulin and
P-Syntabulin, respectively. b-actin was used as an internal control. Pictures shown are representative experiments of four independent experiments. (B) Intensities of total
and phosphorylated syntabulin in cells upon stimulation were quantiﬁed, normalized against the level of b-actin and expressed as fold change of glucose stimulation alone
(control). Data are means ± S.E.M of four independent experiments. *P < 0.05 vs. control. (C) Cells transfected with syntabulin-shRNA or empty vector were stimulated by
16.8 mM glucose alone (control), addition of 10 lM FSK, 100 lM 6-BNZ, or 1 lM ESCA-AM for 30 min, respectively. Insulin secretion level (ng/ml) was normalized against
total cellular protein content in mg and expressed as percentage of empty vector. Data are means ± S.E.M of six independent experiments in duplicate. **P < 0.01 vs. empty
vector.
Y. Ying et al. / FEBS Letters 586 (2012) 3674–3680 3679Acknowledgements
We would like to thank Dr. Xianghong Chen from Graduate
School of Shenzhen Tsinghua University for technical help. This
work was supported by the National Nature Science Foundation
of China (NSFC), Grant No.: 31071255.
Appendix A. Supplementary information
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.febslet.2012.08.
025.
References
[1] Rorsman, P., Eliasson, L., Renström, E., Gromada, J., Barg, S. and Göpel, S. (2000)
The cell physiology of biphasic insulin secretion. News Physiol. Sci. 15, 72–77.
[2] Rhodes, C.J. (2000) Introduction: the molecular cell biology of insulin
production. Semin. Cell. Dev. Biol. 11, 223–225.
[3] Cook, D.L. and Hales, C.N. (1984) Intracellular ATP directly blocks K+ channels
in pancreatic B-cells. Nature 311, 271–273.
[4] Satin, L.S. and Cook, D.L. (1985) Voltage-gated Ca2+ current in pancreatic
B-cells. Pﬂugers. Arch. 404, 385–387.[5] Prentki, M. and Matschinsky, F.M. (1987) Ca2+, cAMP, and phospholipid-
derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev.
67, 1185–1248.
[6] Eliasson, L., Renström, E., Ding, W.G., Proks, P. and Rorsman, P. (1997) Rapid
ATP-dependent priming of secretory granules precedes Ca(2+)-induced
exocytosis in mouse pancreatic B-cells. J. Physiol. 503, 399–412.
[7] Pouli, A.E., Kennedy, H.J., Schoﬁeld, J.G. and Rutter, G.A. (1998) Insulin
targeting to the regulated secretory pathway after fusion with green
ﬂuorescent protein and ﬁreﬂy luciferase. Biochem. J. 15, 669–675.
[8] Varadi, A., Ainscow, E.K., Allan, V.J. and Rutter, G.A. (2002) Involvement of
conventional kinesin in glucose-stimulated secretory granule movements and
exocytosis in clonal pancreatic beta-cells. J. Cell. Sci. 115, 4177–4189.
[9] Seino, S., Shibasaki, T. and Minami, K. (2010) Pancreatic beta-cell signaling:
toward better understanding of diabetes and its treatment. Proc. Jpn. Acad.
Ser. B. Phys. Biol. Sci. 86, 563–577.
[10] Kasai, H., Hatakeyama, H., Ohno, M. and Takahashi, N. (2010) Exocytosis in
islet beta-cells. Adv. Exp. Med. Biol. 654, 305–338.
[11] Bertrand, G., Ishiyama, N., Nenquin, M., Ravier, M.A. and Henquin, J.C. (2002)
The elevation of glutamate content and the ampliﬁcation of insulin secretion
in glucose-stimulated pancreatic islets are not causally related. J. Biol. Chem.
277, 32883–32891.
[12] Hirokawa, N., Noda, Y., Tanaka, Y. and Niwa, S. (2009) Kinesin superfamily
motor proteins and intracellular transport. Nat. Rev. Mol. Cell. Biol. 10, 682–
696.
[13] Rahman, A., Kamal, A., Roberts, E.A. and Goldstein, L.S. (1999) Defective
kinesin heavy chain behavior in mouse kinesin light chain mutants. J. Cell.
Biol. 146, 1277–1288.
3680 Y. Ying et al. / FEBS Letters 586 (2012) 3674–3680[14] Bi, G.Q., Morris, R.L., Liao, G., Alderton, J.M., Scholey, J.M. and Steinhardt, R.A.
(1997) Kinesin- and myosin-driven steps of vesicle recruitment for Ca2+-
regulated exocytosis. J. Cell. Biol. 138, 999–1008.
[15] Meng, Y.X., Wilson, G.W., Avery, M.C., Varden, C.H. and Balczon, R. (1997)
Suppression of the expression of a pancreatic beta-cell form of the kinesin
heavy chain by antisense oligonucleotides inhibits insulin secretion from
primary cultures of mouse beta-cells. Endocrinology 138, 1979–1987.
[16] Su, Q., Cai, Q., Gerwin, C., Smith, C.L. and Sheng, Z.H. (2004) Syntabulin is a
microtubule-associated protein implicated in syntaxin transport in neurons.
Nat. Cell. Biol. 6, 941–953.
[17] Cai, Q., Pan, P.Y. and Sheng, Z.H. (2007) Syntabulin-kinesin-1 family member
5B-mediated axonal transport contributes to activity-dependent presynaptic
assembly. J. Neurosci. 27, 7284–7296.
[18] Molnár, E., Váradi, A., McIlhinney, R.A. and Ashcroft, S.J. (1995) Identiﬁcation
of functional ionotropic glutamate receptor proteins in pancreatic beta-cells
and in islets of Langerhans. FEBS Lett. 371, 253–257.
[19] Cai, Q., Gerwin, C. and Sheng, Z.H. (2005) Syntabulin-mediated anterograde
transport of mitochondria along neuronal processes. J. Cell. Biol. 170, 959–969.
[20] Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y.,
Yano, H., Matsuura, Y., Iwanaga, T., Takai, Y. and Seino, S. (2000) CAMP-GEFII is
a direct target of cAMP in regulated exocytosis. Nat. Cell. Biol. 2, 805–811.
[21] Eliasson, L., Ma, X., Renström, E., Barg, S., Berggren, P.O., Galvanovskis, J.,
Gromada, J., Jing, X., Lundquist, I., Salehi, A., Sewing, S. and Rorsman, P. (2003)
SUR1 regulates PKA-independent cAMP-induced granule priming in mouse
pancreatic B-cells. J. Gen. Physiol. 121, 181–197.[22] Mei, F.C. and Cheng, X. (2005) Interplay between exchange protein directly
activated by cAMP (Epac) and microtubule cytoskeleton. Mol. Biosyst. 1, 325–
331.
[23] Ma, H., Cai, Q., Lu, W., Sheng, Z.H. and Mochida, S. (2009) KIF5B motor adaptor
syntabulin maintains synaptic transmission in sympathetic neurons. J.
Neurosci. 29, 13019–13029.
[24] Shibasaki, T., Takahashi, H., Miki, T., Sunaga, Y., Matsumura, K., Yamanaka, M.,
Zhang, C., Tamamoto, A., Satoh, T., Miyazaki, J. and Seino, S. (2007) Essential
role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by
cAMP. Proc. Natl. Acad. Sci. U S A 104, 19333–19338.
[25] Rorsman, P. and Renström, E. (2003) Insulin granule dynamics in pancreatic
beta cells. Diabetologia 46 (8), 1029–1045.
[26] Holst, J.J. (2007) The physiology of glucagon-like peptide 1. Physiol. Rev. 87,
1409–1439.
[27] Mei, F.C., Qiao, J., Tsygankova, O.M., Meinkoth, J.L., Quilliam, L.A. and Cheng, X.
(2002) Differential signaling of cyclic AMP: opposing effects of exchange
protein directly activated by cyclic AMP and cAMP-dependent protein kinase
on protein kinase B activation. J Biol Chem. 277 (13), 11497–11504.
[28] Magiera, M.M., Gupta, M., Rundell, C.J., Satish, N., Ernens, I. and Yarwood, S.J.
(2004) Exchange protein directly activated by cAMP (EPAC) interacts with the
light chain (LC) 2 of MAP1A. Biochem. J. 382, 803–810.
[29] Okada, Y., Sato-Yoshitake, R. and Hirokawa, N. (1995) The activation of protein
kinase A pathway selectively inhibits anterograde axonal transport of vesicles
but not mitochondria transport or retrograde transport in vivo. J. Neurosci. 15
(4), 3053–3064.
